TIBER CREEK GROUP for PHRMA
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug pricing, reimbursement for prescription drugs, and the pharmaceutical supply chain. Issues related to the illegal importation of prescription drugs. Issues related to capping out of pocket costs. S. 2543 - The Prescription Drug Price Reduction Act. H.R.3 - Lower Drug Costs Now Act of 2019. Issues related to pharmaceutical copayments within the CMS Proposed Notice of Benefit and Payment Parameters Rule for 2021. HR 4100/S 1712, DISARM Act. Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act; Executive Order on Lowering Drug Prices by Putting America First. H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act; Issues related to the Medicaid Drug Rebate Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
Medicare/Medicaid MMM
Issues related to Medicare Part B pricing reform. Issues related to Medicare Part D pricing reform. Proposal to eliminate Medicaid inflationary cap. S. 2543 - The Prescription Drug Price Reduction Act. H.R.3 - Lower Drug Costs Now Act of 2019. Issues related to pharmaceutical copayments within the CMS Proposed Notice of Benefit and Payment Parameters Rule for 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| MATTHEW LEFFINGWELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.